140 related articles for article (PubMed ID: 11231481)
1. Novel method for simultaneous analysis of p53 and K-ras mutations and p53 protein expression in single histologic sections.
Yamashita K; Yoshida T; Shinoda H; Okayasu I
Arch Pathol Lab Med; 2001 Mar; 125(3):347-52. PubMed ID: 11231481
[TBL] [Abstract][Full Text] [Related]
2. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer.
Notarnicola M; Cavallini A; Cardone R; Pezzolla F; Demma I; Di Leo A
Dig Liver Dis; 2000 Mar; 32(2):131-6. PubMed ID: 10975788
[TBL] [Abstract][Full Text] [Related]
3. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
[TBL] [Abstract][Full Text] [Related]
4. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
[TBL] [Abstract][Full Text] [Related]
5. K-ras and p53 gene mutations in colorectal cancer in 57 Japanese patients.
Onda M; Abe R; Tsuchiya A; Fukushima T; Ando Y; Yoshida T
Fukushima J Med Sci; 1997 Jun; 43(1):29-39. PubMed ID: 9431782
[TBL] [Abstract][Full Text] [Related]
6. Synchronous colon carcinomas: molecular-genetic evidence for multicentricity.
Koness RJ; King TC; Schechter S; McLean SF; Lodowsky C; Wanebo HJ
Ann Surg Oncol; 1996 Mar; 3(2):136-43. PubMed ID: 8646513
[TBL] [Abstract][Full Text] [Related]
7. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
8. Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer.
Iinuma H; Okinaga K; Adachi M; Suda K; Sekine T; Sakagawa K; Baba Y; Tamura J; Kumagai H; Ida A
Int J Cancer; 2000 Jul; 89(4):337-44. PubMed ID: 10956407
[TBL] [Abstract][Full Text] [Related]
9. Ras oncogenes and p53 tumor suppressor gene analysis in cardiac myxomas.
Karga H; Papaioannou P; Karayianni M; Papadimitriou K; Priftis D; Voujuklakis T; Migdou B; Nanas J; Papapetrou P
Pathol Res Pract; 2000; 196(9):601-5. PubMed ID: 10997733
[TBL] [Abstract][Full Text] [Related]
10. Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians.
Malhotra P; Anwar M; Nanda N; Kochhar R; Wig JD; Vaiphei K; Mahmood S
Tumour Biol; 2013 Jun; 34(3):1901-11. PubMed ID: 23526092
[TBL] [Abstract][Full Text] [Related]
11. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.
Kusaka T; Fukui H; Sano Y; Ueda Y; Chiba T; Fujimori T
J Gastroenterol Hepatol; 2000 Oct; 15(10):1151-7. PubMed ID: 11106095
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.
Dergham ST; Dugan MC; Kucway R; Du W; Kamarauskiene DS; Vaitkevicius VK; Crissman JD; Sarkar FH
Int J Pancreatol; 1997 Apr; 21(2):127-43. PubMed ID: 9209954
[TBL] [Abstract][Full Text] [Related]
14. Alterations of K-ras and p53 mutations in colorectal cancer patients in Central Europe.
König EA; Köves I; Raşinariu A; Popp AR; Kusser WC; Soyonki K; Kovács A; Glickman BW; Jeney A; Marcsek ZL
J Toxicol Environ Health A; 2001 Mar; 62(5):333-47. PubMed ID: 11261896
[TBL] [Abstract][Full Text] [Related]
15. Mutations of p53, c-kit, K-ras, and beta-catenin gene in non-Hodgkin's lymphoma of adrenal gland.
Nakatsuka S; Hongyo T; Syaifudin M; Nomura T; Shingu N; Aozasa K
Jpn J Cancer Res; 2002 Mar; 93(3):267-74. PubMed ID: 11927008
[TBL] [Abstract][Full Text] [Related]
16. Frequent p53 gene mutations in serrated adenomas of the colorectum.
Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
[TBL] [Abstract][Full Text] [Related]
17. Clonal analysis of colorectal tumors using K-ras and p53 gene mutations as markers.
Dix BR; Robbins PD; Spagnolo DV; Padovan GL; House AK; Iacopetta BJ
Diagn Mol Pathol; 1995 Dec; 4(4):261-5. PubMed ID: 8634782
[TBL] [Abstract][Full Text] [Related]
18. Discordance of p53 mutations of synchronous colorectal carcinomas.
Eguchi K; Yao T; Konomoto T; Hayashi K; Fujishima M; Tsuneyoshi M
Mod Pathol; 2000 Feb; 13(2):131-9. PubMed ID: 10697269
[TBL] [Abstract][Full Text] [Related]
19. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas.
Shibata D; Schaeffer J; Li ZH; Capella G; Perucho M
J Natl Cancer Inst; 1993 Jul; 85(13):1058-63. PubMed ID: 8515492
[TBL] [Abstract][Full Text] [Related]
20. Association of p53 mutations with metastatic prostate cancer.
Eastham JA; Stapleton AM; Gousse AE; Timme TL; Yang G; Slawin KM; Wheeler TM; Scardino PT; Thompson TC
Clin Cancer Res; 1995 Oct; 1(10):1111-8. PubMed ID: 9815901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
